Concessionary capital comes from investors who deliberately accept reduced financial returns relative to conventional market rates to advance defined impact goals.

How it works

Sources include foundations’ program-related investments, development finance institutions, government-backed funds, and family offices with explicit mission mandates. Instruments range from grants and recoverable grants to subordinated debt, revenue-based financing, and equity with capped returns or priority waterfalls favoring mission metrics. Concessionary tranches sometimes catalyze commercial capital by absorbing first-loss risk or funding unproven R&D phases. Impact measurement—jobs created, emissions avoided, users served—sits beside financial reporting. Terms may include reporting covenants and restrictions on asset use. Concessionary capital differs from ESG-mandated market-rate funds that still target competitive IRR.

Why it matters

• Founders: Non-dilutive or patient capital can extend runway in hard-tech or low-income markets, but mixed cap tables need aligned exit expectations.
• Investors: Commercial VCs co-investing should read concessionary terms for liquidation preferences and governance that protect mission over profit in conflicts.
• LPs (impact): Concessionary portfolios trade financial optimization for measurable outcomes—budgeted as part of overall portfolio policy.

Common mistake

Assuming concessionary capital has no strings. Mission covenants, restricted distributions, and capped upside can constrain later VC rounds if not structured cleanly.

Related ideas

Impact investing, catalytic capital, patient capital, blended finance, and ESG investing relate to concessionary capital structures.